328 related articles for article (PubMed ID: 9306401)
1. Stable in vivo gene transduction via a novel adenoviral/retroviral chimeric vector.
Feng M; Jackson WH; Goldman CK; Rancourt C; Wang M; Dusing SK; Siegal G; Curiel DT
Nat Biotechnol; 1997 Sep; 15(9):866-70. PubMed ID: 9306401
[TBL] [Abstract][Full Text] [Related]
2. Adenoviral/retroviral vector chimeras: a novel strategy to achieve high-efficiency stable transduction in vivo.
Bilbao G; Feng M; Rancourt C; Jackson WH; Curiel DT
FASEB J; 1997 Jul; 11(8):624-34. PubMed ID: 9240964
[TBL] [Abstract][Full Text] [Related]
3. In situ generation of pseudotyped retroviral progeny by adenovirus-mediated transduction of tumor cells enhances the killing effect of HSV-tk suicide gene therapy in vitro and in vivo.
Okada T; Caplen NJ; Ramsey WJ; Onodera M; Shimazaki K; Nomoto T; Ajalli R; Wildner O; Morris J; Kume A; Hamada H; Blaese RM; Ozawa K
J Gene Med; 2004 Mar; 6(3):288-99. PubMed ID: 15026990
[TBL] [Abstract][Full Text] [Related]
4. A retroviral vector system 'STITCH' in combination with an optimized single chain antibody chimeric receptor gene structure allows efficient gene transduction and expression in human T lymphocytes.
Weijtens ME; Willemsen RA; Hart EH; Bolhuis RL
Gene Ther; 1998 Sep; 5(9):1195-203. PubMed ID: 9930320
[TBL] [Abstract][Full Text] [Related]
5. Generation of a conditionally neo(r)-containing retroviral producer cell line: effects of neo(r) on retroviral titer and transgene expression.
Wildner O; Candotti F; Krecko EG; Xanthopoulos KG; Ramsey WJ; Blaese RM
Gene Ther; 1998 May; 5(5):684-91. PubMed ID: 9797874
[TBL] [Abstract][Full Text] [Related]
6. Construction of new retroviral producer cells from adenoviral and retroviral vectors.
Lin X
Gene Ther; 1998 Sep; 5(9):1251-8. PubMed ID: 9930327
[TBL] [Abstract][Full Text] [Related]
7. Replicative retroviral vectors for cancer gene therapy.
Solly SK; Trajcevski S; Frisén C; Holzer GW; Nelson E; Clerc B; Abordo-Adesida E; Castro M; Lowenstein P; Klatzmann D
Cancer Gene Ther; 2003 Jan; 10(1):30-9. PubMed ID: 12489026
[TBL] [Abstract][Full Text] [Related]
8. Tumor antigen-specific induction of transcriptionally targeted retroviral vectors from chimeric immune receptor-modified T cells.
Chester J; Ruchatz A; Gough M; Crittenden M; Chong H; Cosset FL; Diaz RM; Harrington K; Alvarez-Vallina L; Vile R
Nat Biotechnol; 2002 Mar; 20(3):256-63. PubMed ID: 11875426
[TBL] [Abstract][Full Text] [Related]
9. Adeno-retroviral chimeric viruses as in vivo transducing agents.
Caplen NJ; Higginbotham JN; Scheel JR; Vahanian N; Yoshida Y; Hamada H; Blaese RM; Ramsey WJ
Gene Ther; 1999 Mar; 6(3):454-9. PubMed ID: 10435096
[TBL] [Abstract][Full Text] [Related]
10. Gene therapy for prostate cancer: toxicological profile of four HSV-tk transducing adenoviral vectors regulated by different promoters.
Ebara S; Shimura S; Nasu Y; Kaku H; Kumon H; Yang G; Wang J; Timme TL; Aguilar-Cordova E; Thompson TC
Prostate Cancer Prostatic Dis; 2002; 5(4):316-25. PubMed ID: 12627218
[TBL] [Abstract][Full Text] [Related]
11. Gene transfer in ovarian cancer cells: a comparison between retroviral and lentiviral vectors.
Indraccolo S; Habeler W; Tisato V; Stievano L; Piovan E; Tosello V; Esposito G; Wagner R; Uberla K; Chieco-Bianchi L; Amadori A
Cancer Res; 2002 Nov; 62(21):6099-107. PubMed ID: 12414634
[TBL] [Abstract][Full Text] [Related]
12. Stable and strictly controlled expression of LTR-flanked autoregulated expression cassettes upon adenoviral transfer.
Unsinger J; Lindenmaier W; May T; Hauser H; Wirth D
Biochem Biophys Res Commun; 2004 Jul; 319(3):879-87. PubMed ID: 15184065
[TBL] [Abstract][Full Text] [Related]
13. A novel single tetracycline-regulative adenoviral vector for tumor-specific Bax gene expression and cell killing in vitro and in vivo.
Gu J; Zhang L; Huang X; Lin T; Yin M; Xu K; Ji L; Roth JA; Fang B
Oncogene; 2002 Jul; 21(31):4757-64. PubMed ID: 12101414
[TBL] [Abstract][Full Text] [Related]
14. Multiply attenuated lentiviral vector achieves efficient gene delivery in vivo.
Zufferey R; Nagy D; Mandel RJ; Naldini L; Trono D
Nat Biotechnol; 1997 Sep; 15(9):871-5. PubMed ID: 9306402
[TBL] [Abstract][Full Text] [Related]
15. Pharmacologically regulated production of targeted retrovirus from T cells for systemic antitumor gene therapy.
Crittenden M; Gough M; Chester J; Kottke T; Thompson J; Ruchatz A; Clackson T; Cosset FL; Chong H; Diaz RM; Harrington K; Alvarez Vallina L; Vile R
Cancer Res; 2003 Jun; 63(12):3173-80. PubMed ID: 12810645
[TBL] [Abstract][Full Text] [Related]
16. Green fluorescent protein in retroviral vector constructs as marker and reporter of gene expression for cell and gene therapy applications.
Eliopoulos N; Galipeau J
Methods Mol Biol; 2002; 183():353-71. PubMed ID: 12136771
[No Abstract] [Full Text] [Related]
17. Exogenous peptide and protein expression levels using retroviral vectors in human cells.
Sandrock TM; Risley B; Richards BT; Poritz MA; Austin HA; Yoo S; Kim MK; Roth B; Repetny K; Hsu F; Stump M; Teng DH; Kamb A
Mol Ther; 2001 Nov; 4(5):398-406. PubMed ID: 11708876
[TBL] [Abstract][Full Text] [Related]
18. Post-mitotic, differentiated myotubes efficiently produce retroviral vector from hybrid adeno-retrovirus templates.
Roberts ML; Athanasopoulos T; Pohlschmidt M; Duisit G; Cosset FL; Dickson G
Gene Ther; 2001 Oct; 8(20):1580-6. PubMed ID: 11704819
[TBL] [Abstract][Full Text] [Related]
19. Simultaneous flow cytometric analyses of enhanced green and yellow fluorescent proteins and cell surface antigens in doubly transduced immature hematopoietic cell populations.
Stull RA; Hyun WC; Pallavicini MG
Cytometry; 2000 Jun; 40(2):126-34. PubMed ID: 10805932
[TBL] [Abstract][Full Text] [Related]
20. Reliable generation of stable high titer producer cell lines for gene therapy.
Rattmann I; Kleff V; Feldmann A; Ludwig C; Sorg UR; Opalka B; Moritz T; Flasshove M
Intervirology; 2007; 50(3):197-203. PubMed ID: 17283445
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
